OX2 Therapeutics touts method to ‘turn off’ protein that suppresses immune system.
Participates in $50 million Series B round for microbe-maker Evelo Biosciences.
Medical device makers big and small may soon be required to report device malfunctions just four times a year instead of within 30 days of an incident.
Growth in all three of the medtech firm’s business segments has pushed it to expand its operations and staff size.
The 60,000-square-foot medtech office building is an early step in Destination Medical Center effort.
The Plymouth medtech company also increased its revenue forecast for its 2017 sales year.
The implantable device is backed by Italy’s Sorin Group and venture capital investors.
It was part of a $12 million Series A round led by Johnson & Johnson Innovation.
The tiny pacemaker was still in working condition after experiencing the turbulence of a rocket launch and the intense pressure of leaving Earth’s atmosphere.